IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.38% | 19.33% | 18.61% | 16.56% | 3.28% |
| Total Depreciation and Amortization | 10.97% | 11.73% | 11.27% | 13.95% | 15.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 329.56% | 360.60% | 2,279.19% | 510.04% | 142.51% |
| Change in Net Operating Assets | -128.05% | -70.76% | -206.27% | -3,040.76% | -35.17% |
| Cash from Operations | 24.96% | 27.21% | 18.68% | -6.54% | 5.12% |
| Capital Expenditure | -4.94% | -3.10% | -0.22% | 6.72% | 2.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.40% | 100.40% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.66% | -22.41% | -818.82% | -201.97% | -207.50% |
| Cash from Investing | -8.05% | 34.20% | 25.15% | 34.16% | 32.67% |
| Total Debt Issued | 562.59% | -- | -- | -- | -- |
| Total Debt Repaid | -471.18% | -471.18% | 31.08% | -104.52% | 70.56% |
| Issuance of Common Stock | 238.67% | 109.84% | 108.49% | -14.77% | -44.11% |
| Repurchase of Common Stock | -8.18% | -44.44% | -93.03% | -167.93% | -359.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.71% | -32.67% | -39.47% | -104.27% | -141.90% |
| Foreign Exchange rate Adjustments | 263.13% | 217.52% | -70.30% | 336.48% | -219.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.66% | 34.69% | -335.69% | -188.18% | -181.61% |